Biotricity Statistics
Total Valuation
Biotricity has a market cap or net worth of 11.46 million. The enterprise value is 38.51 million.
| Market Cap | 11.46M |
| Enterprise Value | 38.51M |
Important Dates
The next estimated earnings date is Friday, June 27, 2025.
| Earnings Date | Jun 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Biotricity has 24.91 million shares outstanding. The number of shares has increased by 96.22% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 24.91M |
| Shares Change (YoY) | +96.22% |
| Shares Change (QoQ) | +7.73% |
| Owned by Insiders (%) | 29.62% |
| Owned by Institutions (%) | n/a |
| Float | 17.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.86 |
| PB Ratio | -0.41 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.69 |
| EV / Sales | 2.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.23
| Current Ratio | 0.23 |
| Quick Ratio | 0.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.83 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -50.53% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 30.60% |
| Revenue Per Employee | 241,200 |
| Profits Per Employee | -260,363 |
| Employee Count | 55 |
| Asset Turnover | 2.31 |
| Inventory Turnover | 1.88 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.91% in the last 52 weeks. The beta is 1.34, so Biotricity's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | -66.91% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 0.42 |
| Relative Strength Index (RSI) | 53.62 |
| Average Volume (20 Days) | 33,623 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.50 |
Income Statement
In the last 12 months, Biotricity had revenue of 13.27 million and -14.32 million in losses. Loss per share was -0.83.
| Revenue | 13.27M |
| Gross Profit | 9.86M |
| Operating Income | -4.64M |
| Pretax Income | -10.67M |
| Net Income | -14.32M |
| EBITDA | -4.63M |
| EBIT | -4.64M |
| Loss Per Share | -0.83 |
Balance Sheet
The company has 2.06 million in cash and 25.46 million in debt, giving a net cash position of -23.40 million or -0.94 per share.
| Cash & Cash Equivalents | 2.06M |
| Total Debt | 25.46M |
| Net Cash | -23.40M |
| Net Cash Per Share | -0.94 |
| Equity (Book Value) | -28.29M |
| Book Value Per Share | -1.30 |
| Working Capital | -16.28M |
Cash Flow
| Operating Cash Flow | -3.15M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 74.31%, with operating and profit margins of -34.96% and -80.42%.
| Gross Margin | 74.31% |
| Operating Margin | -34.96% |
| Pretax Margin | -80.42% |
| Profit Margin | -80.42% |
| EBITDA Margin | -34.92% |
| EBIT Margin | -34.96% |
| FCF Margin | n/a |
Dividends & Yields
Biotricity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -96.22% |
| Shareholder Yield | -96.22% |
| Earnings Yield | -124.96% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 3, 2023. It was a reverse split with a ratio of 0.1666667.
| Last Split Date | Jul 3, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1666667 |
Scores
Biotricity has an Altman Z-Score of -35.54. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -35.54 |
| Piotroski F-Score | n/a |